News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,717 Results
Type
Article (2210)
Company Profile (8)
Press Release (66499)
Section
Business (25414)
Career Advice (35)
Deals (3833)
Drug Delivery (3)
Drug Development (5081)
Employer Resources (6)
FDA (894)
Job Trends (1225)
News (33709)
Policy (1706)
Tag
Academia (99)
Accelerated approval (9)
Allergies (33)
Alliances (1858)
ALS (44)
Alzheimer's disease (171)
Antibody-drug conjugate (ADC) (108)
Approvals (1125)
Artificial intelligence (205)
Autoimmune disease (69)
Automation (23)
Bankruptcy (14)
Best Places to Work (1366)
Biosimilars (53)
Biotechnology (10)
Bladder cancer (101)
Brain cancer (13)
Breast cancer (259)
Cancer (1740)
Cardiovascular disease (133)
Career advice (32)
Career pathing (1)
CAR-T (71)
CDC (1)
Cell therapy (201)
Cervical cancer (16)
Clinical research (6456)
Collaboration (635)
Compensation (417)
Complete response letters (7)
COVID-19 (160)
CRISPR (36)
C-suite (281)
Cystic fibrosis (42)
Data (2130)
Depression (22)
Diabetes (99)
Diagnostics (852)
Digital health (14)
Diversity (1)
Drug discovery (84)
Drug pricing (14)
Drug shortages (1)
Duchenne muscular dystrophy (66)
Earnings (25637)
Employer resources (4)
Events (10793)
Executive appointments (380)
FDA (2064)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (509)
Gene editing (68)
Generative AI (9)
Gene therapy (159)
GLP-1 (128)
Government (179)
Grass and pollen (3)
Guidances (273)
Healthcare (1758)
HIV (31)
Huntington's disease (11)
IgA nephropathy (26)
Immunology and inflammation (29)
Immuno-oncology (13)
Indications (43)
Infectious disease (243)
Inflammatory bowel disease (45)
Inflation Reduction Act (2)
Influenza (26)
Intellectual property (52)
Interviews (2)
IPO (3123)
Job creations (111)
Job search strategy (30)
Kidney cancer (9)
Labor market (8)
Layoffs (21)
Leadership (1)
Legal (387)
Liver cancer (23)
Longevity (4)
Lung cancer (249)
Lymphoma (154)
Machine learning (14)
Management (4)
Manufacturing (201)
MASH (33)
Medical device (1940)
Medtech (1965)
Mergers & acquisitions (1100)
Metabolic disorders (242)
mRNA (4)
Multiple sclerosis (54)
NASH (2)
Neurodegenerative disease (88)
Neuropsychiatric disorders (20)
Neuroscience (501)
NextGen: Class of 2026 (453)
Non-profit (200)
Now hiring (3)
Obesity (100)
Opinion (8)
Ovarian cancer (61)
Pain (36)
Pancreatic cancer (57)
Parkinson's disease (73)
Patents (98)
Patient recruitment (155)
Peanut (12)
People (2599)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (1682)
Phase 2 (2653)
Phase 3 (2530)
Pipeline (2649)
Policy (2)
Postmarket research (186)
Preclinical (608)
Press Release (1)
Prostate cancer (99)
Psychedelics (2)
Radiopharmaceuticals (36)
Rare diseases (252)
Real estate (212)
Recruiting (3)
Regulatory (2172)
Reports (8)
Research institute (166)
Resumes & cover letters (1)
Rett syndrome (21)
RNA editing (1)
RSV (32)
Schizophrenia (40)
Series A (79)
Series B (70)
Sickle cell disease (27)
Special edition (1)
Spinal muscular atrophy (12)
Sponsored (2)
Startups (128)
Stomach cancer (2)
Supply chain (31)
Tariffs (1)
Vaccines (143)
Venture capital (12)
Weight loss (36)
Women's health (29)
Date
Today (29)
Last 7 days (172)
Last 30 days (996)
Last 365 days (10251)
2026 (2045)
2025 (10505)
2024 (6667)
2023 (4631)
2022 (5102)
2021 (5184)
2020 (4749)
2019 (3634)
2018 (2828)
2017 (2325)
2016 (1744)
2015 (2442)
2014 (1706)
2013 (1130)
2012 (1278)
2011 (1504)
2010 (1318)
Location
Africa (40)
Alabama (11)
Alaska (1)
Arizona (32)
Arkansas (5)
Asia (3954)
Australia (500)
California (4337)
Canada (774)
China (258)
Colorado (179)
Connecticut (186)
Delaware (204)
Europe (9039)
Florida (462)
Georgia (84)
Hawaii (3)
Idaho (5)
Illinois (370)
India (19)
Indiana (131)
Iowa (7)
Japan (240)
Kansas (11)
Kentucky (10)
Louisiana (16)
Maine (13)
Maryland (395)
Massachusetts (3225)
Michigan (81)
Minnesota (187)
Mississippi (1)
Missouri (47)
Montana (7)
Nebraska (3)
Nevada (51)
New Hampshire (20)
New Jersey (1036)
New Mexico (6)
New York (1016)
North Carolina (387)
North Dakota (2)
Northern California (2106)
Ohio (111)
Oklahoma (4)
Oregon (12)
Pennsylvania (555)
Puerto Rico (2)
Rhode Island (12)
South America (75)
South Carolina (7)
Southern California (1644)
Tennessee (65)
Texas (621)
United States (14042)
Utah (77)
Virginia (102)
Washington D.C. (13)
Washington State (320)
West Virginia (1)
Wisconsin (90)
68,717 Results for "93".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Antiverse Raises $9.3M Series A to Develop Antibodies for Undruggable Disease Targets and Announces Research Agreement with the Cystic Fibrosis Foundation
March 3, 2026
·
4 min read
Press Releases
Nocion Therapeutics Extends Series B Financing to $93 Million to Support Late-Stage Development of Taplucainium in Chronic Cough
January 8, 2026
·
3 min read
Press Releases
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
December 8, 2025
·
16 min read
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Generic Sterile Injectables Market Size to worth USD 93.39 Billion by 2032, says Coherent Market Insights
October 3, 2025
·
1 min read
Press Releases
CoRegen, Inc. Closes More Than $93 Million Financing
July 10, 2025
·
3 min read
Press Releases
Genome Sequencing Market to Capture USD 101.93 Bn Size Growing at 16.24% CAGR by 2034
September 10, 2025
·
1 min read
Press Releases
Medicinal Herbs Market to Hit US$ 478.93 Billion by 2032, Growing at 11.21% CAGR Driven by Rising Demand for Natural Remedies and Product Innovation
August 11, 2025
·
1 min read
Press Releases
NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress
April 30, 2025
·
3 min read
Press Releases
Penicillin Drug Market to Reach USD 13.93 Billion by 2032, Growing at a CAGR of 3.3% | Coherent Market Insights
June 16, 2025
·
1 min read
1 of 6,872
Next
